Ani Pharmaceuticals ANIP Earnings Call Transcripts

NASDAQ ANIP
$67.79 +0.38 (+0.56%)
At close: Nov 9, 2026 · 4:00 PM EST
12 earnings calls on file for Ani Pharmaceuticals, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Ani Pharmaceuticals Q3 2026 Earnings Call

Nov 5, 2026 11,251 words · 49 min read
  • Nikhil LalwaniPresident and Chief Executive Officer
  • Stephen CareySenior Vice President and Chief Financial Officer
  • Christopher K. MutzSenior Vice President and Head of ANI's Rare Disease Business
  • Gary PowellChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Ani Pharmaceuticals Earnings Call Transcripts

Calls12
LatestNov 5, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 12 Ani Pharmaceuticals transcripts Register to get access to Ani Pharmaceuticals’s earnings call transcripts.